Zion Pharma
United States · Founded 2018
- Employees
- 1–10
- Founded
- 2018
- Business Model
- B2B
- Website
- zionpharma.com
About
Zion Pharma, founded in March 2018, is a clinical-stage biotech company developing novel and differentiated small molecule anti-tumoral therapeutics to address significant unmet needs in oncology. The company maintains research and development operations in Shanghai and Suzhou, China, and has raised institutional financing including a 2020 Series A+ round and a 2021 Series B round led by OrbiMed. In 2023, Zion Pharma entered a global licensing agreement with Roche for its oral small molecule HER2 inhibitor ZN-A-1041.
Summary
Zion Pharma is a Biotech company based in United States, founded in 2018.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...